ADVFN Logo ADVFN
Donnée du Marché
Actualité
Outils
Donnée du Marché
Discover

Hot Features

Follow Feed

Rester connecter avec les traders et investisseurs dans notre communauté Follow Feed.

Flux des Options

Explorez des données complètes sur les options et utilisez les filtres avancés avec Options Flow.

Moniteur

Organisez et surveillez vos d'actions et actifs avec le Moniteur.
Se connecter Premium IconPremium Help Menu
CAC 40
7 570,20
0,00%
Dow Jones
38 834,86
0,15%
DAX
18 067,56
0,00%
Brent Oil
84,565
-0,15%
Bitcoin
65 489,02
0,80%
Registration Strip Icon for charts Inscrivez-vous pour des graphiques en temps réel, des outils d'analyse et des prix.
S'inscrire
  1. Accueil
  2. Investir
  3. Actions
  4. Etats-Unis
  5. NASDAQ
  6. Zentalis Pharmaceuticals Inc (ZNTL)

  7. Zentalis Pharmaceuticals Inc (ZNTL) Actualités

ZNTL Zentalis Pharmaceuticals Inc

4,21
-4,18 (-49,82%)
19 Juin 2024 - Fermé
Retardé de 15 minutes
Nom Action Symbole Action Marché Type
Zentalis Pharmaceuticals Inc ZNTL NASDAQ Action ordinaire
  Variation Action Variation Action% Cours Dernier Dernier échange
Upgrade Icon
-4,18 -49,82% 4,21 01:59:42
Ouverture Plus Bas Plus Haut Prix de clôture Clôture Veille
6,29 3,9301 6,40 4,14 8,39
plus d'informations sur les cotations »

Actualités Recentes

Date Heure Source Titre
18/6/202413:00GLOBEZentalis Pharmaceuticals Provides Update on Azenosertib..
04/6/202400:00GLOBEZentalis Pharmaceuticals Announces Inducement Grants Under..
03/6/202413:00EDGAR2Form 8-K - Current report
30/5/202413:00GLOBEZentalis Pharmaceuticals to Present at the Jefferies Global..
29/5/202413:16EDGAR2Form DEFA14A - Additional definitive proxy soliciting..
29/5/202413:04EDGAR2Form 8-K - Current report
29/5/202413:00GLOBEZentalis Pharmaceuticals Announces Appointment of..
23/5/202423:01GLOBEZentalis Pharmaceuticals to Present Promising Results from..
14/5/202413:00GLOBEZentalis Pharmaceuticals to Present at TD Cowen 5th Annual..
07/5/202413:05EDGAR2Form 10-Q - Quarterly report [Sections 13 or 15(d)]
07/5/202413:03EDGAR2Form 8-K - Current report
07/5/202413:00GLOBEZentalis Pharmaceuticals Reports First Quarter 2024..
01/5/202423:30GLOBEZentalis Pharmaceuticals Announces Inducement Grants Under..
02/4/202422:05GLOBEZentalis Pharmaceuticals to Highlight Preclinical Data..
01/4/202423:30GLOBEZentalis Pharmaceuticals Announces Inducement Grants Under..
02/3/202400:00GLOBEZentalis Pharmaceuticals Announces Inducement Grants Under..
29/2/202423:20EDGAR2Form S-8 - Securities to be offered to employees in employee..
29/2/202423:14EDGAR2Form S-3ASR - Automatic shelf registration statement of..
28/2/202413:00GLOBEZentalis Pharmaceuticals to Participate in Upcoming Investor..
27/2/202413:08EDGAR2Form 10-K - Annual report [Section 13 and 15(d), not S-K..
27/2/202413:04EDGAR2Form 8-K - Current report
27/2/202413:00GLOBEZentalis Pharmaceuticals Reports Full Year 2023 Financial..
15/2/202422:12EDGAR2Form 8-K - Current report
14/2/202401:43EDGAR2Form SC 13G/A - Statement of acquisition of beneficial..
13/2/202413:00GLOBEZentalis Pharmaceuticals to Participate in the Oppenheimer..
13/2/202402:25EDGAR2Form 144 - Report of proposed sale of securities
13/2/202402:25EDGAR2Form 144 - Report of proposed sale of securities
13/2/202402:22EDGAR2Form 4 - Statement of changes in beneficial ownership of..
06/2/202401:15EDGAR2Form 4 - Statement of changes in beneficial ownership of..
06/2/202401:14EDGAR2Form 4 - Statement of changes in beneficial ownership of..
06/2/202401:12EDGAR2Form 4 - Statement of changes in beneficial ownership of..
06/2/202401:11EDGAR2Form 4 - Statement of changes in beneficial ownership of..
03/2/202403:29EDGAR2Form 144 - Report of proposed sale of securities
03/2/202403:29EDGAR2Form 144 - Report of proposed sale of securities
03/2/202403:28EDGAR2Form 144 - Report of proposed sale of securities
03/2/202403:27EDGAR2Form 144 - Report of proposed sale of securities
03/2/202403:26EDGAR2Form 144 - Report of proposed sale of securities
01/2/202423:00GLOBEZentalis Pharmaceuticals Announces Inducement Grants Under..
25/1/202413:03EDGAR2Form 8-K - Current report
25/1/202413:00GLOBEZentalis Pharmaceuticals Strengthens Management Team with..
08/1/202413:03EDGAR2Form 8-K - Current report
08/1/202413:00BWImmunome Exclusively Licenses Zentalis ROR1 Antibody-Drug..
04/1/202402:21EDGAR2Form 4 - Statement of changes in beneficial ownership of..
04/1/202402:19EDGAR2Form 3 - Initial statement of beneficial ownership of..
02/1/202422:49GLOBEZentalis Pharmaceuticals Announces Inducement Grants Under..
21/12/202323:47EDGAR2Form 4 - Statement of changes in beneficial ownership of..
01/12/202323:39GLOBEZentalis Pharmaceuticals Announces Inducement Grants Under..
13/11/202323:24EDGAR2Form 4 - Statement of changes in beneficial ownership of..
13/11/202323:24EDGAR2Form 4 - Statement of changes in beneficial ownership of..
09/11/202313:00GLOBEZentalis to Participate in Investor Call Focused on Ovarian..

Dernières Valeurs Consultées

NASDAQ
ZNTL
Zentalis Pharmaceuticals
USOTC
DODRW
Diamond Offshore Drilling (PK)
BIT
P1YEC9
NLBNPIT1YEC9 20240920 220
Delayed Upgrade Clock
ADVFN Logo
InvestorsHub

France
Société
Entreprise
Popular
Obtenir l'application
App Store
Google Play

Assistance: support@advfn.fr

En accédant aux services disponibles de ADVFN, vous acceptez les Conditions Générales de ADVFN Conditions Générales

© 2024 ADVFN PLC - Tous droits réservés